Buyout funds are piling into Indian hospital chains and medical firms, lured by rising spending on healthcare in the world’s most populous nation, with the sector providing a rare bright spot amid a downturn in overall deal activity.
Private equity and venture capital investment in India’s health and pharmaceutical sector hit a record of about $5.5bn in 2023, a 25 per cent jump on the previous year, according to a report published by Bain & Company on Thursday.
Global private equity executives from firms including Bain Capital and Blackstone Group, as well as KKR co-founder Henry Kravis, have visited India in recent months, talking up its economic potential and pledging multibillion-dollar acquisitions.
您已閱讀17%（711字），剩余83%（3505字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。